Unichem Labs has outperformed the sector today by 2.15%. Stock has been gaining for the last 3 days and has risen 5.20% in the period and today it opened with a gain of 2.2%. The stock price today touched an intraday high of Rs 204.40 (4.74%).
The market is happy that Unichem Labs has received the final approval for its ANDA, Tadalafil Tablets, 2.5 mg, 5 mg 10 mg and 20 mg from the US FDA for a generic version of ELI LILLY's Cialiss, 2.5 mg, 5 mg, 10 mg and 20 mg.
Unichem's Tadalafil Tablets are indicated for the treatment of erectile dysfunction (ED), signs and symptoms of benign prostatic hyperplasia and (BPH) and ED and the signs and symptoms of BPH (EDIBPH).
This approval comes close on the heels of another approval it got on 13th March. This was an ANDA nod for its Allopurinol Tablets from the USFDA to market a generic version of ZYLOPRIM (allopurinol) Tablets. These are used for management of patients with signs and symptoms of primary or secondary gout (acute attacks, tophi, joint destruction, uric acid lithiasis, and/or nephropathy).